OS-123 Progression and risk factors after treatment with tenofovir or entecavir for chronic hepatitis B based on a multistate modeling approach

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Hepatology

Topics

Medicine

Epidemiology

Internal Medicine

Hepatology

Human Immunodeficiency Virus (Hiv)

Show all topics

DOI

10.1016/s0168-8278(24)00564-6